Publicaciones en colaboración con investigadores/as de Hospital Universitario 12 de Octubre (135)

2024

  1. Experience With Bexarotene to Treat Cutaneous T-Cell Lymphomas: A Study of the Spanish Working Group of Cutaneous Lymphomas

    Actas Dermo-Sifiliograficas, Vol. 115, Núm. 6, pp. 547-554

  2. Hair repigmentation in Sézary syndrome

    Journal of the European Academy of Dermatology and Venereology

  3. Intralesional brentuximab vedotin for the treatment of primary cutaneous T-cell lymphomas: a case series

    International Journal of Dermatology

  4. Mogamulizumab combined with extracorporeal photopheresis for the treatment of refractory mycosis fungoides and Sézary syndrome. Report of seven cases

    Journal of the European Academy of Dermatology and Venereology

2023

  1. Brentuximab vedotin in the treatment of cutaneous T-cell lymphomas: Data from the Spanish Primary Cutaneous Lymphoma Registry

    Journal of the European Academy of Dermatology and Venereology, Vol. 37, Núm. 1, pp. 57-64

  2. Cost of Treating Cutaneous T-Cell Lymphoma in Spain: Analysis of MICADOS Study Data by Disease Stage

    Actas Dermo-Sifiliograficas

  3. EORTC consensus recommendations for the treatment of mycosis fungoides/Sézary syndrome – Update 2023

    European Journal of Cancer, Vol. 195

  4. Evaluating the Accuracy of Self-Collected Swabs for the Diagnosis of Mpox

    Clinical Infectious Diseases, Vol. 76, Núm. 7, pp. 1311-1314

  5. International Society for Cutaneous Lymphomas Pandemic Section (ICLYPS) analysis of cutaneous T-cell lymphoma outcomes during the COVID-19 pandemic: A retrospective cohort study

    Journal of the American Academy of Dermatology, Vol. 88, Núm. 4, pp. 935-937

  6. NanoString analysis of mycosis fungoides reveals individual molecular identity

    British Journal of Dermatology

  7. Primary Cutaneous Lymphoma Registry of the Spanish Academy of Dermatology and Venereology (AEDV): Data for the First 5 Years

    Actas Dermo-Sifiliograficas, Vol. 114, Núm. 4, pp. 291-298

  8. Real-Life Barriers to Diagnosis of Early Mycosis Fungoides: An International Expert Panel Discussion

    American Journal of Clinical Dermatology, Vol. 24, Núm. 1, pp. 5-14

  9. Viral dynamics in patients with monkeypox infection: a prospective cohort study in Spain

    The Lancet Infectious Diseases, Vol. 23, Núm. 4, pp. 445-453

  10. [Translated article] Spanish Version of the RECAP Questionnaire to Assess Control of Atopic Eczema: Translation, Cultural Adaptation, Validation, and Correlations With Other Patient-Reported Outcome Measures

    Actas Dermo-Sifiliograficas, Vol. 114, Núm. 6, pp. T488-T493

  11. pTERT C250T mutation: A potential biomarker of poor prognosis in metastatic melanoma

    Heliyon, Vol. 9, Núm. 8

2022

  1. Activity and safety of topical pimecrolimus in patients with early stage mycosis fungoides (PimTo-MF): a single-arm, multicentre, phase 2 trial

    The Lancet Haematology, Vol. 9, Núm. 6, pp. e425-e433

  2. Advanced-Stage CD30+ Mycosis Fungoides Treated With Brentuximab

    Actas Dermo-Sifiliograficas, Vol. 113, Núm. 5, pp. 529-531

  3. Clinical presentation and virological assessment of confirmed human monkeypox virus cases in Spain: a prospective observational cohort study

    The Lancet, Vol. 400, Núm. 10353, pp. 661-669

  4. Contemporary treatment patterns and response in relapsed/refractory cutaneous T-cell lymphoma (CTCL) across five european countries

    Cancers, Vol. 14, Núm. 1

  5. Drug reaction with eosinophilia and systemic symptoms in a 10-year-old boy sparing lichen planus lesions: an example of reverse isotopic response

    Journal of the European Academy of Dermatology and Venereology